Ecallantide: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Ecallantide. Educational only — not medical advice.
Labeled uses
KALBITOR® (ecallantide) is indicated for treatment of acute attacks of hereditary angioedema (HAE) in patients 12 years of age and older.
Source: FDA labeling via NIH DailyMed (set f56aec67…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.